On November 2, 2022 Sutro Biopharma, Inc. (Sutro or the Company) (NASDAQ: STRO), a clinical-stage oncology company pioneering site-specific and novel-format antibody drug conjugates (ADCs), reported that Bill Newell, Chief Executive Officer, will participate in two upcoming investor conferences (Press release, Sutro Biopharma, NOV 2, 2022, View Source [SID1234622769]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Presentation Details:

Credit Suisse 31st Annual Healthcare Conference
Format: Presentation
Date: Wednesday, November 9, 2022
Time: 11:35 a.m. ET / 8:35 a.m. PT
Location: Rancho Palos Verdes, CA

Jefferies London Healthcare Conference
Format: Presentation
Date: Thursday, November 17, 2022
Time: 12:55 p.m. GMT / 7:55 a.m. ET / 4:55 a.m. PT
Location: London

The presentations will be accessible through the News & Events page of the Investor Relations section of the company’s website at www.sutrobio.com. Archived replays will be available for at least 30 days after the event.